Embecta-Tidepool Partnership Highlights Opportunities in Type 2 Diabetes Market
Embecta has partnered with Tidepool to create a type-2-specific AID insulin pump system. This move highlights a quickly growing market with the potential for lucrative future opportunities.
Meet Sequenex at this Year’s ADA Scientific Sessions
Sequenex is heading to the 2023 American Diabetes Association Scientific Sessions in June. Stop by our booth to learn about our services and find out how we can help your company develop innovative connected software solutions.
Abbott Pain Relief System with Connected App Receives FDA Approval
Abbott’s Proclaim XR SCS integrates with a useful smartphone application. Its success highlights the importance of seamless connectivity in modern medical devices.
Diabetes Care Technology Coming In 2023
2023 could be the year we finally see a truly closed-loop automated insulin dosing system. Even if not, there is still a plethora of remarkable diabetes technology set to make its debut this year. Find out what’s coming in insulin pumps, pens, CGMs, and looped systems.
Advancements & Opportunities in Continuous Glucose Monitoring
Current research into improving the accuracy and usability of continuous glucose monitors has left few stones unturned. From sweat-based sensors to contact lenses, boundless opportunities are waiting to be explored in this arena. Find out which of those opportunities holds the most promise and how your company can capitalize on advancements in this technology.